Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at Digestive Disease Week

B DUBLIN, May 1, 2026 /PRNewswire/ — Keenova Therapeutics plc announced today that a new presentation on hepatorenal syndrome-acute kidney injury (HRS‑AKI) and TERLIVAZ® (terlipressin) will…
posteditor
posteditor
Articles: 21727

Other News